BAY-593

N/A

Report date: 2024/08/02 17:44:04
NME

Base Information

Drug NameBAY-593
Drug Alias NameBAY-593
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTranscriptional coactivator YAP1 inhibitorsTAZ and TEAD interaction inhibitorTafazzin inhibitors
TargetsTranscriptional coactivator YAP1Tafazzin
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesBayer AG
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A